Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The KATP channel is an octameric complex composed of four pore-forming Kir6.x subunits and four regulatory sulfonylurea receptor (SURx) subunits. It links cellular metabolism to membrane excitability by regulating K+ efflux in response to intracellular ATP and ADP levels. This channel plays crucial roles in various tissues including pancreatic β cells, cardiac muscle, vascular smooth muscle, skeletal muscle, and the brain, affecting processes such as insulin secretion, vasodilation, and protection against ischemia.
Sulfonylureas inhibit KATP channels via binding to SUR subunits, leading to membrane depolarization and insulin release. KATP channel openers like Pinacidil activate the channel leading to hyperpolarization and smooth muscle relaxation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-Sensitive Potassium Channel (KATP channel).